Radiotherapy-induced nausea, vomiting associated with worsening quality of life
the ONA take:
Patients’ subjective experiences of radiotherapy-induced nausea and vomiting (RINV) correlated to the worsening of quality of life outcomes, according to a new study published online ahead of print in the journal Supportive Care in Cancer.
For the study, researchers enrolled 58 patients with gastrointestinal cancer undergoing treatment with abdominal radiotherapy alone or with concomitant chemoradiotherapy.
The investigators recorded all episodes of nausea, vomiting, and antiemetic use daily for the treatment period and the week following completion of treatment.
Results showed that in total, 351 episodes of nausea severity, duration, onset time, and 154 outcomes of vomiting onset times and contents were recorded. The most common durations of nausea were 30 minutes or less and consistent nausea all day and night.
Researchers found that longer nausea duration, greater nausea severities, the location of nausea experienced, and the onset timing and number of vomiting episodes significantly negatively impacted quality of life.
The findings suggest that the identification and amelioration of these RINV experiences could improve quality of life in patients with gastrointestinal cancer receiving radiotherapy.
Patients’ subjective experiences of radiotherapy-induced nausea and vomiting (RINV) correlated to the worsening of quality of life outcomes.
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Vitamin D Supplementation is Recommended for Pediatric Patients With Sarcoma
- Extended Adjuvant Therapy for Breast Cancer Improves 5-Year Disease-free Survival
- A Structured Group Exercise Program for Patients With Metastatic Cancer Receiving Chemotherapy and CTNNB1 (β-catenin) as a Biomarker of Exercise Efficacy
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|